证券代码：301580 证券简称：爱迪特 公告编号：2025-013 爱迪特（秦皇岛）科技股份有限公司 第三届监事会第十五次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 爱迪特（秦皇岛）科技股份有限公司（以下简称"公司"）第三届监事会 第十五次会议于 2025 年 4 月 28 日在秦皇岛市经济技术开发区都山路 9 号公司会 议室以现场结合通讯方式召开。会议通知于 2025年 4月 17日以电子邮件的方式 向全体监事发出。会议由监事会主席肖振瑞先生召集并主持。会议应出席监事 3 人，实际出席监事 3 人，监事崔怡然女士以通讯方式出席会议。会议召集及召 开程序符合《公司法》等法律法规、规范性文件和《公司章程》的有关规定。 二、监事会会议审议情况 （一）审议通过《关于公司〈2024 年年度报告〉及其摘要的议案》 监事会认为：公司《2024 年年度报告》的编制程序符合法律、行政法规和 中国证监会的规定，报告内容真实、准确、完整地反映了公司的实际情况，不 存在虚假记载、误导性陈述或者重大遗漏。 具体内容详见公司同日在中国证监会指 ...

证券代码： 301580 证券简称：爱迪特 公告编号： 2025-012 公司《2024 年年度报告》的编制程序符合法律、行政法规和中国证监会的 规定，报告内容真实、准确、完整地反映了公司的实际情况，不存在虚假记载、 误导性陈述或者重大遗漏。 本议案已经公司董事会审计委员会审议通过。 具体内容详见公司同日在中国证监会指定的创业板信息披露网站巨潮资讯 网（www.cninfo.com.cn）刊登的《2024 年年度报告》。 表决结果：9 票赞成；0 票反对；0 票弃权；0 票回避。 本议案尚需提交股东会审议。 爱迪特（秦皇岛）科技股份有限公司 第三届董事会第十九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 爱迪特（秦皇岛）科技股份有限公司（以下简称"公司"）第三届董事会 第十九次会议于 2025 年 4 月 28 日在秦皇岛市经济技术开发区都山路 9 号公司会 议室以现场与通讯方式相结合的方式召开。会议通知于 2025年 4月 17日以电子 邮件的方式向全体董事和相关与会人员发出。会议由董事长李洪文先生召集并 主持。会议 ...

证券代码：301580 证券简称：爱迪特 公告编号：2025-003 爱迪特（秦皇岛）科技股份有限公司 关于 2024 年度利润分配及资本公积转增股本预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.以公司现有总股本 7,611.7527 万股为基数，向全体股东每 10 股派发现金 红利 6.5 元（含税），合计派发现金红利 49,476,392.55 元，同时以资本公积金 向全体股东每 10股转增 4股，合计转增 3,044.70108万股，转增后公司总股本将 增加至 10,656.45378 万股（最终转增数量以中国证券登记结算有限公司深圳分 公司实际转增结果为准），不送红股，2024 年度剩余未分配利润结转以后年度。 2.若在本次利润分配预案披露日至实施权益分派股权登记日期间，公司总 股本由于股份回购、可转债转股、股权激励行权、增发新股上市等原因而发生 变化，则按照分配比例不变的原则对分配总额进行调整。 3.公司现金分红方案不涉及《深圳证券交易所创业板股票上市规则》第 9.4 条相关规定的可能被实施其他风险警示情形。 爱迪特 ...

中信建投证券股份有限公司 关于爱迪特（秦皇岛）科技股份有限公司 2024 年度募集资金存放与使用情况的专项核查报告 中信建投证券股份有限公司（以下简称"中信建投证券"或"保荐机构"） 作为爱迪特（秦皇岛）科技股份有限公司（以下简称"爱迪特"或"公司"）首 次公开发行股票的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证 券交易所创业板股票上市规则》和《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》等有关规定，对爱迪特 2024 年度募集资金存放与使用情况进 行了核查，发表如下保荐意见： 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 根据中国证券监督管理委员会《关于同意爱迪特（秦皇岛）科技股份有限公 司首次公开发行股票注册的批复》（证监许可〔2023〕2615 号），公司于 2024 年 6 月向社会公众公开发行人民币普通股（A 股）1,902.9382 万股，每股发行价 为 44.95 元，募集资金总额为人民币 85,537.07 万元，根据有关规定扣除发行费 用后，实际募集资金净额为 76,131.57 万元，该募集资金已于 2024 年 6 月到账。 上述资金到账情况业经 ...

中信建投证券股份有限公司 关于爱迪特（秦皇岛）科技股份有限公司 关于2025年度日常关联交易预计的核查意见 中信建投证券股份有限公司（以下简称"中信建投"、"保荐机构"）作为爱迪 特（秦皇岛）科技股份有限公司（以下简称"爱迪特"、"公司"）首次公开发行股 票的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券交易所上市 公司自律监管指引第 13 号——保荐业务》《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等相关规定，对爱迪特 2025 年度日常关联交易预计的事项进行了审慎核查，具 体情况如下： 一、日常关联交易基本情况 （一）日常关联交易概述 根据公司及控股子公司 2024 年度日常关联交易的实际情况，结合公司业务发展 需要，预计公司及控股子公司 2025 年度与相关关联方可能发生的日常关联交易总金 额为不超过人民币 8,500.00 万元（不含税）。2024 年度，公司及控股子公司与相关 关联方的预计交易金额为不超过人民币 9,500.00 万元，实际发生的交易金额为人民 币 6,460.97 万元。 公司于 2025 年 4 月 ...

Financial Performance - The company's revenue for Q1 2025 was ¥205,392,055, representing an increase of 18.07% compared to ¥173,961,209 in the same period last year[5] - Net profit attributable to shareholders was ¥31,271,385.80, a growth of 34.21% from ¥23,299,888.83 year-on-year[5] - The basic earnings per share (EPS) was ¥0.4108, showing a slight increase of 0.66% from ¥0.4081 in the same quarter last year[5] - The net profit for the current period is CNY 30,466,904.35, an increase of 30.5% compared to CNY 23,407,535.69 in the previous period[20] - Operating profit for the current period is CNY 34,198,502.35, up from CNY 26,548,829.39, reflecting a growth of 28.5%[20] - Total comprehensive income for the current period is CNY 30,012,749.11, compared to CNY 23,639,898.44 in the previous period, indicating an increase of 27.5%[21] Cash Flow - The net cash flow from operating activities reached ¥22,267,479.84, a significant increase of 271.83% compared to a negative cash flow of ¥12,958,838.82 in the previous year[5] - Cash flow from operating activities shows a net inflow of CNY 22,267,479.84, a significant recovery from a net outflow of CNY 12,958,838.82 in the previous period[21] - Cash flow from investing activities has a net inflow of CNY 33,490,700.58, down from CNY 192,655,455.86 in the previous period[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,293,814,316.32, reflecting a marginal increase of 0.26% from ¥2,287,843,452.73 at the end of the previous year[5] - Current assets totaled ¥1,914,102,023.90, slightly increasing from ¥1,909,332,075.29 at the beginning of the period[17] - Total liabilities decreased to ¥224,866,582.55 from ¥245,319,949.37, a reduction of 8.29%[18] - The total equity attributable to shareholders increased to ¥2,017,166,556.28 from ¥1,988,525,265.46, reflecting a growth of 1.44%[18] Expenses - The company reported a 36.96% increase in management expenses, totaling ¥21,672,318.02, primarily due to higher salaries for senior management and increased depreciation expenses[8] - Total operating costs amounted to ¥175,393,128.26, up from ¥147,343,738.56, reflecting a growth of 19.06%[19] - The operating cost specifically for goods sold was ¥100,652,125.63, compared to ¥84,306,283.80 in the prior period, indicating a rise of 19.43%[19] - The company incurred research and development expenses of CNY 12,802,274.95, an increase from CNY 10,710,324.27 in the previous period[20] - The company’s total tax expenses for the current period are CNY 3,934,457.38, compared to CNY 3,116,545.64 in the previous period, reflecting an increase of 26.2%[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 8,036[10] - The largest shareholder, Tianjin Yuan Yi Enterprise Management Consulting Center, holds 17.91% of shares, totaling 13,630,000 shares[10] - Tianjin Wendi Enterprise Management Consulting Center holds 10.99% of shares, totaling 8,363,918 shares[10] - The foreign shareholder, HAL, holds 7.51% of shares, totaling 5,713,534 shares[10] - The total number of shares held by the top 10 shareholders accounts for a significant portion of the company's equity, indicating concentrated ownership[10] - There are no changes in the number of restricted shares for major shareholders during the reporting period[13] - The company has a lock-up period of 36 months for shares held by Tianjin Yuan Yi and Tianjin Wendi[13] Investment and Market Activity - Investment income rose by 85.84% to ¥2,151,218.98, attributed to increased returns from financial investments and joint ventures[8] - The company experienced an 82.62% decrease in net cash flow from investing activities, amounting to ¥33,490,700.58, mainly due to the purchase of liquidity products[8] - The company has not disclosed any new product developments or market expansion strategies during the call[12] - There are no indications of mergers or acquisitions discussed in the conference call[12] - The company has not provided specific future performance guidance or outlook in the reported documents[12]

Financial Performance - The company's operating revenue for 2024 reached ¥888,165,246.91, representing a 13.81% increase compared to ¥780,383,700.00 in 2023[20]. - Net profit attributable to shareholders for 2024 was ¥150,491,664.18, a 2.40% increase from ¥146,959,201.90 in 2023[20]. - The net cash flow from operating activities for 2024 was ¥150,098,058.16, up 7.14% from ¥140,091,445.87 in 2023[20]. - The total assets at the end of 2024 amounted to ¥2,287,843,452.73, an increase of 77.12% from ¥1,291,720,904.45 at the end of 2023[20]. - The net assets attributable to shareholders at the end of 2024 were ¥1,988,525,265.46, reflecting an 85.65% increase from ¥1,071,142,657.12 at the end of 2023[20]. - The basic earnings per share for 2024 decreased by 12.06% to ¥2.26 from ¥2.57 in 2023[20]. - The company reported a quarterly revenue of ¥247,035,522.11 in Q4 2024, contributing to a total annual revenue growth[22]. - The company achieved a revenue growth with overseas revenue share increasing from 44.5% in 2021 to 61.85% in 2024, with a compound annual growth rate of 138.7% for the overseas local operation team[54]. - The company reported a long-term effective classification for its dental zirconia ceramic materials, indicating a focus on high-quality dental restorations[86]. Dividends and Capital Reserves - The company plans to distribute a cash dividend of 6.5 yuan per 10 shares (including tax) to all shareholders, based on a total of 76,117,527 shares[3]. - The company will also increase capital reserves by converting 4 shares for every 10 shares held by shareholders[3]. Governance and Management - The financial report has been confirmed as true, accurate, and complete by the company's responsible persons and accounting heads[3]. - All board members attended the meeting to review the annual report, ensuring collective responsibility for its content[3]. - The company has a comprehensive governance structure in place, as outlined in the corporate governance section of the report[5]. - The company emphasizes the importance of understanding the differences between plans, forecasts, and commitments in forward-looking statements[3]. - The company has established a performance evaluation and incentive mechanism, linking management compensation to operational performance metrics[155]. - The board of directors consists of 9 members, including 3 independent directors with expertise in accounting, law, and industry background, complying with legal requirements[151]. - The company maintains a fully independent financial accounting system, with separate bank accounts and no shared accounts with the controlling shareholder[163]. - The company has a complete and independent business system, including R&D, production, and sales capabilities, without reliance on the controlling shareholder[166]. - The company has established an audit committee under the board to oversee internal and external audits, ensuring compliance and effectiveness[158]. Research and Development - R&D investment reached 47.36 million yuan, representing an 18.21% year-on-year increase, with a total of 153 valid patents held by the company as of December 31, 2024[58]. - R&D investment amounted to ¥47,361,902.27 in 2024, representing 5.33% of operating revenue[79]. - The company is developing a new dental zirconia material that can be sintered in 30 to 60 minutes, enhancing production efficiency[77]. - The company is working on a digital cloud system for dental management to improve customer service efficiency and satisfaction[77]. - The company is focusing on innovative materials, such as zirconia and glass ceramics, for dental restorations, which are currently in various stages of registration[81]. Market Expansion and Strategy - The company plans to continue expanding its market presence and investing in new product development to drive future growth[28]. - The company has actively expanded into emerging markets such as Southeast Asia, the Middle East, and Australia, further increasing market share[54]. - The company aims to reduce the bonding failure rate of zirconia veneers through a new surface treatment agent[78]. - The company is exploring acquisition opportunities, targeting firms with complementary technologies valued at approximately $100 million[177]. - The company plans to pursue external investments and acquisitions to enhance its industry position and integrate cutting-edge technologies globally[126]. Product Development and Innovation - The company has developed a product ecosystem covering dental restoration, implants, orthodontics, and prevention, enhancing customer satisfaction and loyalty[56]. - The company is committed to continuous technological innovation and product upgrades to maintain its leading position in the industry amidst competitive pressures[37]. - The company has introduced a new line of porcelain powders suitable for customized denture crowns, targeting adults over 18 years old[82]. - The company has registered new products, including dental films and CAD/CAM materials, with registration valid until 2029[83]. - The company is focusing on expanding its product offerings in the dental sector, particularly in the area of ceramic restorations[83]. Financial Management and Cash Flow - Operating cash inflow for 2024 reached ¥930,987,237.26, a year-on-year increase of 10.48% compared to ¥842,665,047.90 in 2023[95]. - Financing cash inflow for 2024 was ¥794,007,249.81, marking a significant increase due to funds raised from the IPO[95]. - The net increase in cash and cash equivalents for 2024 was ¥132,304,919.96, down 57.04% from ¥307,965,654.67 in 2023[95]. - The company has confirmed that all projects are on schedule and have not encountered significant changes in feasibility[117]. Shareholder Engagement and Communication - The company conducted multiple investor communication activities in July 2024, including phone meetings and on-site research with various institutional investors[143][144][145]. - The company ensures equal treatment of all shareholders and upholds the rights of minority shareholders during shareholder meetings[149]. - The company continues to engage with shareholders through regular meetings and transparent communication[167]. Employee and Talent Management - The total number of employees at the end of the reporting period is 959, with 782 from the parent company and 177 from major subsidiaries[195]. - The company plans to strengthen its talent pool by focusing on recruiting high-end marketing and international management talents[134]. - The educational background of employees shows 127 with master's degrees or above, 439 with bachelor's degrees, and 393 with associate degrees or below[196]. Compliance and Risk Management - The company has obtained necessary certifications for its products in major international markets, including FDA and CE certifications, to mitigate compliance risks[138]. - The company will actively monitor international market policies to address potential tariff impacts on exports to the U.S.[141]. - The company has not reported any significant changes in its operational strategy during the reporting period[170].

2、召开方式：线上会议 3、交流内容：公司将针对 2024 年年度经营成果、财务指标等与投资者进 行交流，并对投资者普遍关注的问题进行回答。 4、出席人员：董事长、总经理李洪文先生；董事会秘书、副总经理郜雨女 士；财务总监孔祥乾先生；独立董事贾国军先生；董事王雪松女士。（具体以 当天实际参会人员为准） 证券代码： 301580 证券简称：爱迪特 公告编号： 2025-001 爱迪特（秦皇岛）科技股份有限公司 关于召开 2024 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 爱迪特（秦皇岛）科技股份有限公司（以下简称"公司"）将于 2025 年 4 月 29日在巨潮资讯网（www.cninfo.com.cn）披露《2024年年度报告》。为加强 与投资者交流，使投资者更全面、深入地了解公司经营情况，公司将于 2025 年 4 月 29 日（星期二）召开 2024 年度业绩说明会。 一、业绩说明会安排 1、召开时间：2025 年 4 月 29 日（星期二）15:00-16:00 问题征集二维码 三、咨询方式 咨询机构：爱迪特（秦皇岛）科技股份 ...

| | □特定对象调研 | □分析师会议 | | --- | --- | --- | | 投资者关系 | □媒体采访 | □业绩说明会 | | 活动类别 | □新闻发布会 | □路演活动 | | | 团现场参观 | | | | □其他 （请文字说明其他活动内容） | | | 参与单位名称 | 招商证券 张语馨 国泰基金 任一林 | | | 及人员姓名 | | | | 时间 | 2025年1月13日 | | | 地点 | 公司会议室 | | | 上市公司接待 | 董事会秘书 部雨 | | | 人员姓名 | 投资者问答主要内容: | | | | 1. 公司如何看待国内的价格竞争? | | | 答: | | | | | 在前些年国内确实出现过低价竞争的情况,但从结果来看 | | | 投资者关系活动 主要内容介绍 | 优质产品是能够被客户认知和认可的。伴随着中国口腔行业发 | | | | 展成熟度越来越高,以及公司通过长期研发投入获得了一定市 | | | | 场和客户的认可与信赖,给客户提供技术领先、质量稳定、价 | | | | 格适中的产品成为公司核心竞争力。 | | | | 2. 目前销售氧化链结构如何变化? | ...

证券代码：301580 证券简称：爱迪特 | --- | --- | |-------|-------------------------------------------------------------| | | | | | 2. 公司存货周转水平上升的原因是什么？ 答： | | | 存货增加系阶段性的波动导致。首先，公司今年更新 ERP | | | 系统，上线 SAP 系统对公司海内外分支做高效管理，在此期间 | | | 增加了安全库存储备以保障系统切换期间订单的及时交付；第 | | | 二，针对个别区域的发展需求，公司对海外仓适当增加了一定 | | | 存货。 | | | 3. 公司设立美国、德国子公司负责欧美核心市场的运营，但日、 | | | 韩两国相比欧美市场规模较小却设立子公司基于何种考虑？ | | | 答： | | | 日、韩两国口腔市场发展较为成熟，在国际上认可度较高， | | | 公司在日韩设立子公司进行本土化运营旨在提升公司产品竞 | | | | | | 争力和品牌知名度。 | | | 4. 公司沃兰种植体销售情况如何？ | | | 答： | | | 公司收购沃兰后渠道整合及市场拓展 ...